Rethinking clinical endpoints in kidney transplant trials

Keyphrases

• Clinical Endpoints 100%
• Kidney Transplant 100%
• Surrogate Endpoint 100%
• Long-term Clinical Outcome 66%
• Kidney Transplantation 33%
• Glomerular Filtration Rate 33%
• Albuminuria 33%
• Randomized Controlled Trial 33%
• Novel Therapeutics 33%
• Trial Design 33%
• Patient Well-being 33%
• Follow-up Interval 33%
• Low Dose Rate 33%
• Composite Endpoint 33%
• New Therapies 33%
• Organ Transplantation 33%
• Histological Score 33%
• Graft Loss 33%
• Transplant Experiment 33%
• Outcome Reporting 33%
• Protocol Biopsy 33%
• Treatment Safety 33%
• Transplantation Therapy 33%
• Death Loss 33%
• Safety Quality 33%
• Statistical Strategy 33%
• Donor-specific Alloantibody 33%
• Surrogate Standard 33%
• Multiple Primary Endpoints 33%
• Reporting Strategies 33%

Medicine and Dentistry

• Kidney Graft 100%
• Clinical Endpoint 100%
• Kidney Transplantation 33%
• Glomerular Filtration Rate 33%
• Graft Failure 33%
• Quality of Life 33%
• Albuminuria 33%
• Randomized Controlled Trial 33%
• Organ Transplantation 33%
• Biopsy Technique 33%
• Alloantibody 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Graft Failure 100%
• Albuminuria 100%
• Randomized Controlled Trial 100%
• Alloantibody 100%